Jun 4, 2026 07:30AM
Jun 2, 2026 07:00AM
Jun 2, 2026 07:00AM
May 12, 2026 04:05PM
May 1, 2026 12:15PM
May 1, 2026 12:15PM
Mar 25, 2026 07:02AM Rezolute (RZLT) Reiterated at Neutral by Cantor Fitzgerald After FDA Meeting
Mar 25, 2026 06:58AM
Mar 25, 2026 06:37AM
Mar 25, 2026 05:33AM
Mar 24, 2026 03:40PM
Mar 24, 2026 07:00AM
Mar 24, 2026 07:00AM
Feb 12, 2026 04:05PM Rezolute Reports Second Quarter Fiscal 2026 Financial Results and Provides Business Update
Jan 8, 2026 04:13AM
Jan 7, 2026 07:00AM
Jan 7, 2026 07:00AM
Dec 12, 2025 06:43AM
Dec 11, 2025 07:00AM
Dec 11, 2025 07:00AM
Nov 6, 2025 04:05PM Rezolute Reports First Quarter Fiscal 2026 Financial Results and Provides Business Update
Sep 18, 2025 05:27AM
Sep 17, 2025 04:05PM
Sep 3, 2025 06:49AM
Sep 2, 2025 07:30AM
Sep 2, 2025 07:30AM
May 28, 2025 02:27PM
May 28, 2025 08:02AM Rezolute Inc. (RZLT) Announces Completion of Enrollment in the Phase 3 sunRIZE Study of Ersodetug in Patients with Congenital Hyperinsulinism
May 28, 2025 08:00AM
May 13, 2025 04:05PM
May 5, 2025 08:02AM
May 5, 2025 08:00AM
Feb 12, 2025 04:05PM
Feb 5, 2025 06:40AM
Feb 4, 2025 08:00AM Rezolute Inc. (RZLT) Provides Update on its Phase 3 sunRIZE Study of Ersodetug
Feb 4, 2025 08:00AM
Jan 7, 2025 08:02AM
Jan 7, 2025 08:00AM
Dec 5, 2024 08:00AM
Dec 4, 2024 06:01AM
Dec 3, 2024 08:00AM
Dec 3, 2024 08:00AM FDA Grants Orphan Drug Designation to Rezolute’s Ersodetug (RZ358) for the Treatment of Hypoglycemia Due to Tumor Hyperinsulinism
Sep 27, 2024 06:50AM
Sep 20, 2024 11:55AM
Sep 20, 2024 05:22AM
Sep 19, 2024 04:05PM
Sep 10, 2024 06:43AM
Sep 9, 2024 11:58AM
Sep 9, 2024 08:38AM Jones Trading Reiterates Buy Rating on Rezolute (RZLT) following FDA lift of clinical hold on RZ358
Sep 9, 2024 07:30AM

322,245 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All